Soterix Medical Inc. is a leading global provider of innovative medical treatments for neuropsychiatric and neurological disorders and rehabilitation. With over 850 medical centers worldwide, Soterix Medical specializes in non-invasive neuromodulation and offers a comprehensive range of clinical systems and portable units to clinicians and patients. Their extensive intellectual property portfolio includes High-Definition transcranial Direct Current Stimulation (HD-tDCS), Limited Total Energy tDCS (LTE-tDCS), and Neurotargeting, making them a trusted leader in the field.
Founded in 2008, Soterix Medical is committed to bringing advanced medical technology to those in need, with ongoing clinical trials and multiple worldwide clinical approvals. In addition to their core focus on neuromodulation, Soterix Medical also distributes synergistic technologies and provides services in image analysis, modeling, consumer product human factors, and defense and space applications. With a strong presence in the Tri-state area and international distributors in major markets, Soterix Medical is dedicated to engineering solutions that serve humanity.
Generated from the website